Generics

AAM welcomed testimony in which U.S. Trade Representative Robert Lightizer said the free trade agreement currently being negotiated will not contain a provision requiring 10-years of biologic exclusivity.

The Zytiga brand and generic had a market value of approximately $454 million for the most recent 12 months ended March 2020, according to IQVIA.

Tecfidera had a market value of roughly $3.78 billion for the 12 months ended April 30, according to IQVIA.

Zydus Cadila’s generic Jadenu will be available in dosage strengths of 90 mg, 180 mg and 360 mg.

The FDA has revoked its emergency use authorization for the drugs to treat COVID-19 based on results from a large clinical trial that showed no benefit for decreasing death or speeding recovery.

The Colcrys brand and generic had a market value of approximately $491 million for the most recent 12 months ended March 2020, according to IQVIA.

The product, a "follow-on" biologic of Sanofi's Lantus, has been approved in both vial and prefilled pen presentations.

Everolimus tablets had a market value of roughly $435 million in the 12 months endedApril 2020, according to IQVIA.